← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Appili Therapeutics Inc
$2,121,025
Total funding
2
Grants
Funding over time
peak $1.2M · FY2017–19$2M$1.5M$1M$500K$0
'17
'18
'19
Funding mix
By agency
DOD$2,121,025 · 2
By mechanism
—$2,121,025 · 2
Investigators at Appili Therapeutics Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
DEVELOPMENT OF A NEGAMYCIN ANALOGUE TARGETING THE TRANSLATIONAL MACHINERY IN GRAM-NEGATIVE DRUG-RESISTANT PATHOGENS FOR THE TREATMENT OF INFECTIONS$1,226,658
· FY2017 · Department of the Army
A NOVEL NEGAMYCIN ANALOGUE FOR THE TREATMENT OF MULTI-DRUG RESISTANT GRAM-NEGATIVE BACTERIAL INFECTION$894,367
· FY2019 · Defense Health Agency